In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
- In a randomized, double-blind Phase 2 trial, SELLAS's galinpepimut-S demonstrated improvement in overall survival and doubling of progression-free survival in mesothelioma patients